{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:13:05Z","timestamp":1793149985966,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20220818102801004"],"award-info":[{"award-number":["JCYJ20220818102801004"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20220818102801004"],"award-info":[{"award-number":["JCYJ20220818102801004"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20220818102801004"],"award-info":[{"award-number":["JCYJ20220818102801004"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20220818102801004"],"award-info":[{"award-number":["JCYJ20220818102801004"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong High-level Hospital Construction Fund Clinical Research Project of Shenzhen Children\u2019s Hospital","award":["LCYJ2022059"],"award-info":[{"award-number":["LCYJ2022059"]}]},{"name":"Guangdong High-level Hospital Construction Fund Clinical Research Project of Shenzhen Children\u2019s Hospital","award":["LCYJ2022059"],"award-info":[{"award-number":["LCYJ2022059"]}]},{"name":"Guangdong High-level Hospital Construction Fund Clinical Research Project of Shenzhen Children\u2019s Hospital","award":["LCYJ2022059"],"award-info":[{"award-number":["LCYJ2022059"]}]},{"name":"Guangdong High-level Hospital Construction Fund Clinical Research Project of Shenzhen Children\u2019s Hospital","award":["LCYJ2022059"],"award-info":[{"award-number":["LCYJ2022059"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated fatty liver disease (MAFLD) has become the most prevalent chronic liver condition in adolescents. The triglyceride-glucose (TyG) index, a surrogate marker of insulin resistance, has shown promise in adult MAFLD detection but requires pediatric-specific validation, particularly when combined with anthropometric measures. This study investigated the association between modified TyG indices and MAFLD, and evaluated their predictive value in adolescents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study analyzed data from 532 adolescents (12\u201318\u00a0years) in the 2017\u20132020 National Health and Nutrition Examination Survey (NHANES) with complete records. MAFLD diagnosis was based on transient elastography plus metabolic criteria. The investigators employed multivariate linear regression and restricted cubic splines (RCS) to examine linear and nonlinear relationships between modified TyG indices and CAP values. Subgroup analyses were stratified by obesity status, and sensitivity analyses were performed on the NAFLD cohort (n\u2009=\u2009527). Receiver operating characteristic (ROC) curve analysis, using Youden's index, evaluated the predictive performance of TyG indices for MAFLD identification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 130 MAFLD adolescents (vs 402 controls), modified TyG indices demonstrated significantly stronger associations with CAP in fully adjusted models compared to the original TyG index. TyG-WC showed the highest diagnostic accuracy (AUC\u2009=\u20090.923, 95%CI:0.900\u20130.947), followed by TyG-BMI (AUC\u2009=\u20090.917) and TyG-WHtR (AUC\u2009=\u20090.915), while the original TyG index performed poorly (AUC\u2009=\u20090.673). Subgroup analyses revealed particularly strong associations in non-obese participants, and sensitivity analyses confirmed result robustness after excluding potential confounders. Optimal cutoff values provided clinically useful screening thresholds, with TyG-WC achieving 94% sensitivity at 665.94.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrates that modified TyG indices incorporating anthropometric parameters (particularly TyG-WC) significantly outperform the original TyG index for MAFLD detection in adolescents, with superior diagnostic accuracy (AUC 0.915\u20130.923). The robust predictive performance maintained in sensitivity analyses and non-obese subgroups supports their clinical utility as simple, non-invasive screening tools for pediatric MAFLD risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-025-03915-x","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T01:34:10Z","timestamp":1746063250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Modified triglyceride-glucose indices as novel predictors of metabolic dysfunction-associated fatty liver disease in US adolescents: a nationally representative study from NHANES 2017\u20132020"],"prefix":"10.1186","volume":"25","author":[{"given":"Yigui","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baixian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeling","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongling","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"3915_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2024.103043","volume":"55","author":"E Amini-Salehi","year":"2024","unstructured":"Amini-Salehi E, Letafatkar N, Norouzi N, Joukar F, Habibi A, Javid M, et al. Global prevalence of nonalcoholic fatty liver disease: an updated review meta-analysis comprising a population of 78 million from 38 countries. Arch Med Res. 2024;55: 103043. https:\/\/doi.org\/10.1016\/j.arcmed.2024.103043.","journal-title":"Arch Med Res"},{"key":"3915_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s12519-024-00814-1","volume":"20","author":"EJ Lee","year":"2024","unstructured":"Lee EJ, Choi M, Ahn SB, Yoo J-J, Kang SH, Cho Y, et al. Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysis. World J Pediatr. 2024;20:569\u201380. https:\/\/doi.org\/10.1007\/s12519-024-00814-1.","journal-title":"World J Pediatr"},{"key":"3915_CR3","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1210\/clinem\/dgaa753","volume":"106","author":"A Bardugo","year":"2021","unstructured":"Bardugo A, Bendor CD, Zucker I, Lutski M, Cukierman-Yaffe T, Derazne E, et al. Adolescent nonalcoholic fatty liver disease and type 2 diabetes in young adulthood. J Clin Endocrinol Metab. 2021;106:e34-44. https:\/\/doi.org\/10.1210\/clinem\/dgaa753.","journal-title":"J Clin Endocrinol Metab"},{"key":"3915_CR4","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1186\/s12889-024-19047-y","volume":"24","author":"J Lv","year":"2024","unstructured":"Lv J, Zhang Y, Li X, Guo H, Yang C. The burden of non-alcoholic fatty liver disease among working-age people in the Western Pacific Region, 1990\u20132019: an age\u2013period\u2013cohort analysis of the Global Burden of Disease study. BMC Public Health. 2024;24:1852. https:\/\/doi.org\/10.1186\/s12889-024-19047-y.","journal-title":"BMC Public Health"},{"key":"3915_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73:202\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039.","journal-title":"J Hepatol"},{"key":"3915_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.cgh.2021.11.038","volume":"21","author":"GEH Lim","year":"2023","unstructured":"Lim GEH, Tang A, Ng CH, Chin YH, Lim WH, Tan DJH, et al. An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD. Clin Gastroenterol Hepatol. 2023;21:619-629.e7. https:\/\/doi.org\/10.1016\/j.cgh.2021.11.038.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3915_CR7","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1016\/j.cgh.2021.02.030","volume":"20","author":"J Liu","year":"2022","unstructured":"Liu J, Ayada I, Zhang X, Wang L, Li Y, Wen T, et al. Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults. Clin Gastroenterol Hepatol. 2022;20:e573\u201382. https:\/\/doi.org\/10.1016\/j.cgh.2021.02.030.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3915_CR8","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","volume":"24","author":"Y-L Fang","year":"2018","unstructured":"Fang Y-L, Chen H, Wang C-L, Liang L. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From \u201ctwo hit theory\u201d to \u201cmultiple hit model.\u201d WJG. 2018;24:2974\u201383. https:\/\/doi.org\/10.3748\/wjg.v24.i27.2974.","journal-title":"WJG"},{"key":"3915_CR9","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.3748\/wjg.v29.i25.3999","volume":"29","author":"SC Pal","year":"2023","unstructured":"Pal SC, M\u00e9ndez-S\u00e1nchez N. Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis. World J Gastroenterol. 2023;29:3999\u20134008. https:\/\/doi.org\/10.3748\/wjg.v29.i25.3999.","journal-title":"World J Gastroenterol"},{"key":"3915_CR10","doi-asserted-by":"publisher","unstructured":"Sun Y, Ji H, Sun W, An X, Lian F. Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases. Eur J Intern Med. 2024;:S0953620524003753. https:\/\/doi.org\/10.1016\/j.ejim.2024.08.026.","DOI":"10.1016\/j.ejim.2024.08.026"},{"key":"3915_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12944-017-0409-6","volume":"16","author":"S Zhang","year":"2017","unstructured":"Zhang S, Du T, Zhang J, Lu H, Lin X, Xie J, et al. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16:15. https:\/\/doi.org\/10.1186\/s12944-017-0409-6.","journal-title":"Lipids Health Dis"},{"key":"3915_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/6417205","volume":"2024","author":"X Feng","year":"2024","unstructured":"Feng X, Deng Y, Chen C, Liu X, Huang Y, Feng Y. Predictive value of triglyceride-glucose index for all-cause and cardiovascular mortality in patients with diabetes mellitus: a retrospective study. Int J Endocrinol. 2024;2024: 6417205. https:\/\/doi.org\/10.1155\/2024\/6417205.","journal-title":"Int J Endocrinol"},{"key":"3915_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12944-023-01954-5","volume":"22","author":"M Wang","year":"2023","unstructured":"Wang M, Chang M, Shen P, Wei W, Li H, Shen G. Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease. Lipids Health Dis. 2023;22:186. https:\/\/doi.org\/10.1186\/s12944-023-01954-5.","journal-title":"Lipids Health Dis"},{"key":"3915_CR14","doi-asserted-by":"publisher","first-page":"20470","DOI":"10.1038\/s41598-023-47269-4","volume":"13","author":"P Zeng","year":"2023","unstructured":"Zeng P, Cai X, Yu X, Gong L. Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population. Sci Rep. 2023;13:20470. https:\/\/doi.org\/10.1038\/s41598-023-47269-4.","journal-title":"Sci Rep"},{"key":"3915_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1321922","volume":"15","author":"H Liu","year":"2024","unstructured":"Liu H, Chen J, Qin Q, Yan S, Wang Y, Li J, et al. Association between TyG index trajectory and new-onset lean NAFLD: a longitudinal study. Front Endocrinol. 2024;15: 1321922. https:\/\/doi.org\/10.3389\/fendo.2024.1321922.","journal-title":"Front Endocrinol"},{"key":"3915_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41598-017-18854-1","volume":"8","author":"Z Gu","year":"2018","unstructured":"Gu Z, Li D, He H, Wang J, Hu X, Zhang P, et al. Body mass index, waist circumference, and waist-to-height ratio for prediction of multiple metabolic risk factors in Chinese elderly population. Sci Rep. 2018;8:385. https:\/\/doi.org\/10.1038\/s41598-017-18854-1.","journal-title":"Sci Rep"},{"key":"3915_CR17","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1139\/apnm-2016-0410","volume":"42","author":"S Lee","year":"2017","unstructured":"Lee S, Kuk JL, Boesch C, Arslanian S. Waist circumference is associated with liver fat in black and white adolescents. Appl Physiol Nutr Metab. 2017;42:829\u201333. https:\/\/doi.org\/10.1139\/apnm-2016-0410.","journal-title":"Appl Physiol Nutr Metab"},{"key":"3915_CR18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1186\/s12889-017-4868-5","volume":"17","author":"M-S Lin","year":"2017","unstructured":"Lin M-S, Lin T-H, Guo S-E, Tsai M-H, Chiang M-S, Huang T-J, et al. Waist-to-height ratio is a useful index for nonalcoholic fatty liver disease in children and adolescents: a secondary data analysis. BMC Public Health. 2017;17:851. https:\/\/doi.org\/10.1186\/s12889-017-4868-5.","journal-title":"BMC Public Health"},{"key":"3915_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12944-021-01568-9","volume":"20","author":"J Cai","year":"2021","unstructured":"Cai J, Lin C, Lai S, Liu Y, Liang M, Qin Y, et al. Waist-to-height ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population. Lipids Health Dis. 2021;20:145. https:\/\/doi.org\/10.1186\/s12944-021-01568-9.","journal-title":"Lipids Health Dis"},{"key":"3915_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2024.1426749","volume":"11","author":"W Xie","year":"2024","unstructured":"Xie W, Hong Y, Chen X, Wang S, Zhang F, Chi X. Waist-to-hip ratio and nonalcoholic fatty liver disease: a clinical observational and Mendelian randomization analysis. Front Nutr. 2024;11: 1426749. https:\/\/doi.org\/10.3389\/fnut.2024.1426749.","journal-title":"Front Nutr"},{"key":"3915_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102416","volume":"10","author":"M Borges-Canha","year":"2022","unstructured":"Borges-Canha M, Neves J, Silva M, Mendon\u00e7a F, Moreno T, Ribeiro S, et al. Waist-to-Hip ratio and inflammatory parameters are associated with risk of non-alcoholic fatty liver disease in patients with morbid obesity. Biomedicines. 2022;10: 2416. https:\/\/doi.org\/10.3390\/biomedicines10102416.","journal-title":"Biomedicines"},{"key":"3915_CR22","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","volume":"66","author":"T Karlas","year":"2017","unstructured":"Karlas T, Petroff D, Sasso M, Fan J-G, Mi Y-Q, De L\u00e9dinghen V, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66:1022\u201330. https:\/\/doi.org\/10.1016\/j.jhep.2016.12.022.","journal-title":"J Hepatol"},{"key":"3915_CR23","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","volume":"6","author":"M Eslam","year":"2021","unstructured":"Eslam M, Alkhouri N, Vajro P, Baumann U, Weiss R, Socha P, et al. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. Lancet Gastroenterol Hepatol. 2021;6:864\u201373. https:\/\/doi.org\/10.1016\/S2468-1253(21)00183-7.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3915_CR24","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00431-020-03570-2","volume":"179","author":"LE Simental-Mend\u00eda","year":"2020","unstructured":"Simental-Mend\u00eda LE, Gamboa-G\u00f3mez CI, Aradillas-Garc\u00eda C, Rodr\u00edguez-Mor\u00e1n M, Guerrero-Romero F. The triglyceride and glucose index is a useful biomarker to recognize glucose disorders in apparently healthy children and adolescents. Eur J Pediatr. 2020;179:953\u20138. https:\/\/doi.org\/10.1007\/s00431-020-03570-2.","journal-title":"Eur J Pediatr"},{"key":"3915_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biology11050685","volume":"11","author":"K Song","year":"2022","unstructured":"Song K, Lee HW, Choi HS, Park G, Lee HS, Kim SJ, et al. Comparison of the modified TyG indices and other parameters to predict non-alcoholic fatty liver disease in youth. Biology. 2022;11: 685. https:\/\/doi.org\/10.3390\/biology11050685.","journal-title":"Biology"},{"key":"3915_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092251","volume":"10","author":"S Song","year":"2022","unstructured":"Song S, Son D-H, Baik S-J, Cho W-J, Lee Y-J. Triglyceride glucose-waist circumference (TyG-WC) is a reliable marker to predict non-alcoholic fatty liver disease. Biomedicines. 2022;10: 2251. https:\/\/doi.org\/10.3390\/biomedicines10092251.","journal-title":"Biomedicines"},{"key":"3915_CR27","doi-asserted-by":"publisher","first-page":"S19 \u201340","DOI":"10.2337\/dc23-S002","volume":"46 Supplement_1","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and diagnosis of diabetes: standards of care in diabetes\u20142023. Diabetes Care. 2023;46 Supplement_1:S19-40. https:\/\/doi.org\/10.2337\/dc23-S002.","journal-title":"Diabetes Care"},{"key":"3915_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1429413","volume":"11","author":"Q Ning","year":"2024","unstructured":"Ning Q, Zheng K, Yan J, Zhu C. Triglyceride glucose index as a predictor for non-alcoholic fatty liver disease: insights from a longitudinal analysis in non-obese individuals. Front Med (Lausanne). 2024;11: 1429413. https:\/\/doi.org\/10.3389\/fmed.2024.1429413.","journal-title":"Front Med (Lausanne)"},{"key":"3915_CR29","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s12020-021-02815-w","volume":"74","author":"M Malek","year":"2021","unstructured":"Malek M, Khamseh ME, Chehrehgosha H, Nobarani S, Alaei-Shahmiri F. Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus. Endocrine. 2021;74:538\u201345. https:\/\/doi.org\/10.1007\/s12020-021-02815-w.","journal-title":"Endocrine"},{"key":"3915_CR30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.orcp.2023.09.005","volume":"17","author":"J-H Lee","year":"2023","unstructured":"Lee J-H, Jeon S, Lee HS, Kwon Y-J. Association between waist circumference trajectories and incident non-alcoholic fatty liver disease. Obes Res Clin Pract. 2023;17:398\u2013404. https:\/\/doi.org\/10.1016\/j.orcp.2023.09.005.","journal-title":"Obes Res Clin Pract"},{"key":"3915_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1123\/ijsnem.2014-0256","volume":"26","author":"NM Pimenta","year":"2016","unstructured":"Pimenta NM, Santa-Clara H, Melo X, Cortez-Pinto H, Silva-Nunes J, Sardinha LB. Waist-to-hip ratio is related to body fat content and distribution regardless of the waist circumference measurement protocol in nonalcoholic fatty liver disease patients. Int J Sport Nutr Exerc Metab. 2016;26:307\u201314. https:\/\/doi.org\/10.1123\/ijsnem.2014-0256.","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"3915_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/jhn.12410","volume":"30","author":"NM Pimenta","year":"2017","unstructured":"Pimenta NM, Cortez-Pinto H, Melo X, Silva-Nunes J, Sardinha LB, Santa-Clara H. Waist-to-height ratio is independently related to whole and central body fat, regardless of the waist circumference measurement protocol, in non-alcoholic fatty liver disease patients. J Human Nutr Diet. 2017;30:185\u201392. https:\/\/doi.org\/10.1111\/jhn.12410.","journal-title":"J Human Nutr Diet"},{"key":"3915_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2023.102160","volume":"47","author":"A Ismaiel","year":"2023","unstructured":"Ismaiel A, Hosiny BE, Ismaiel M, Leucuta D-C, Popa S-L, Catana CS, et al. Waist to height ratio in nonalcoholic fatty liver disease - Systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2023;47: 102160. https:\/\/doi.org\/10.1016\/j.clinre.2023.102160.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"3915_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12944-024-02207-9","volume":"23","author":"X Liu","year":"2024","unstructured":"Liu X, Tang Y, Luo Y, Gao Y, He L. Role and mechanism of specialized pro-resolving mediators in obesity-associated insulin resistance. Lipids Health Dis. 2024;23:234. https:\/\/doi.org\/10.1186\/s12944-024-02207-9.","journal-title":"Lipids Health Dis"},{"key":"3915_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/nu16183120","volume":"16","author":"Y Fu","year":"2024","unstructured":"Fu Y, Hua Y, Alam N, Liu E. Progress in the study of animal models of metabolic dysfunction-associated steatotic liver disease. Nutrients. 2024;16: 3120. https:\/\/doi.org\/10.3390\/nu16183120.","journal-title":"Nutrients"},{"key":"3915_CR36","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/s12876-023-03007-8","volume":"23","author":"S Li","year":"2023","unstructured":"Li S, Feng L, Ding J, Zhou W, Yuan T, Mao J. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults. BMC Gastroenterol. 2023;23:376. https:\/\/doi.org\/10.1186\/s12876-023-03007-8.","journal-title":"BMC Gastroenterol"},{"key":"3915_CR37","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.2169\/internalmedicine.1097-22","volume":"62","author":"N Otsubo","year":"2023","unstructured":"Otsubo N, Fukuda T, Cho G, Ishibashi F, Yamada T, Monzen K. Utility of indices obtained during medical checkups for predicting fatty liver disease in non-obese people. Intern Med. 2023;62:2307\u201319. https:\/\/doi.org\/10.2169\/internalmedicine.1097-22.","journal-title":"Intern Med"},{"key":"3915_CR38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12944-020-01409-1","volume":"19","author":"Y Li","year":"2020","unstructured":"Li Y, Zheng R, Li J, Feng S, Wang L, Huang Z. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study. Lipids Health Dis. 2020;19:229. https:\/\/doi.org\/10.1186\/s12944-020-01409-1.","journal-title":"Lipids Health Dis"},{"key":"3915_CR39","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1136\/flgastro-2018-101119","volume":"11","author":"M Phipps","year":"2020","unstructured":"Phipps M, Wattacheril J. Non-alcoholic fatty liver disease (NAFLD) in non-obese individuals. Frontline Gastroenterol. 2020;11:478\u201383. https:\/\/doi.org\/10.1136\/flgastro-2018-101119.","journal-title":"Frontline Gastroenterol"},{"key":"3915_CR40","doi-asserted-by":"publisher","first-page":"6488","DOI":"10.1038\/s41598-023-33753-4","volume":"13","author":"N Wu","year":"2023","unstructured":"Wu N, Li J, Zhang J, Yuan F, Yu N, Zhang F, et al. Waist circumference mediates the association between rs1260326 in GCKR gene and the odds of lean NAFLD. Sci Rep. 2023;13:6488. https:\/\/doi.org\/10.1038\/s41598-023-33753-4.","journal-title":"Sci Rep"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03915-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03915-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T01:34:11Z","timestamp":1746063251000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03915-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3915"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03915-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,1]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by The National Center for Health Statistics (NCHS) Research Ethics Review Board. Written informed consent to participate in this study was provided by the participants\u2019 legal guardian\/next of kin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"325"}}